Effect of sulfhydryl inhibitors and membrane-active drugs on platelet reactions.
D000227:Adenine Nucleotides / Q000378:metabolism; D000251:Adenosine Triphosphatases / Q000097:blood; D001792:Blood Platelets / Q000187:drug effects*; D002247:Carbon Isotopes; D002462:Cell Membrane / Q000187:drug effects; D002729:Chloromercuribenzoates / Q000494:pharmacology*; D002746:Chlorpromazine / Q000494:pharmacology; D005033:Ethylmaleimide / Q000494:pharmacology*; D006801:Humans; D007099:Imipramine / Q000494:pharmacology; D010973:Platelet Adhesiveness / Q000187:drug effects; D011398:Promethazine / Q000494:pharmacology; D013438:Sulfhydryl Compounds / Q000037:antagonists & inhibitors*; D013917:Thrombin / Q000494:pharmacology
D000227:Adenine Nucleotides; D002247:Carbon Isotopes; D002729:Chloromercuribenzoates; D013438:Sulfhydryl Compounds; D013917:Thrombin; D000251:Adenosine Triphosphatases; D011398:Promethazine; D005033:Ethylmaleimide; D007099:Imipramine; D002746:Chlorpromazine